Santoro A, Improta CM, Sarina B, Mannina D, De Philippis C, Taurino D, Mariotti J, Balzarotti M, Bramanti S. Brentuximab vedotin plus nivolumab as bridging therapy to CAR T-cells in relapsed/refractory primary mediastinal B-cell lymphoma. haematol [Internet]. 2020Sep.10 [cited 2025Dec.5];. Available from: https://haematologica.org/article/view/12281